Perceptive Informatics Named Winner in the European Outsourcing Awards - Recognized for Its Truly Integrated eClinical Solution

Perceptive Informatics Named Winner in the European Outsourcing Awards -
Recognized for Its Truly Integrated eClinical Solution

BOSTON, Oct. 29 /PRNewswire-FirstCall/ -- Perceptive Informatics, a leading
eClinical solutions provider and subsidiary of PAREXEL International
Corporation (Nasdaq: PRXL), announced today that it has been named the winner
of the Best e-Business/IT Strategy Category in The European Outsourcing Awards
2009. The winning entry from Perceptive Informatics titled "Gaining a Complete
Trial Picture to Make More Effective Decisions in Real-Time: Realizing Key
Benefits of a Truly Integrated eClinical Solution" focused on a customer's
success story using Perceptive's eClinical Suite.

The award was presented to Perceptive Informatics at The European Outsourcing
Awards 2009 Gala, held on October 14, 2009 in Madrid, Spain. The European
Outsourcing Awards are designed to recognize new and significant developments
in contract services and reward companies for their outstanding contributions
and achievements. The awards were created to celebrate excellence in a number
of areas across the biopharmaceutical industry, including technology.

According to Kevin Robinson, Ph.D., head of The European Outsourcing Awards
judging panel and Editor of Pharma Magazine, "The European Outsourcing Award
for the Best e-Business/IT Strategy, which was evaluated by an independent
panel of judges, recognizes the leadership role Perceptive Informatics has
established in the area of eClinical technologies. Perceptive Informatics has
demonstrated its excellence based on effectively using IT to create a
significant, exploitable competitive and operational advantage. This award
recognizes Perceptive for its well thought-through and executed strategy,
addressing not only the deployment of technology but also its effective uptake
by users."

"Perceptive Informatics is honored to be chosen by the judges as the winner of
the Best e-Business/IT Strategy Category in The European Outsourcing Awards,"
said Steve Kent, President, Perceptive Informatics, a PAREXEL Company. "We
have addressed the opportunity to maximally leverage technology through our
eClinical Suite, which we believe provides customers with the industry's most
integrated solution. Perceptive is committed to continuing to lead innovation,
developing the next generation of technologies that are aligned to accelerate
clinical development."

The eClinical Suite from Perceptive Informatics represents a new level of
integration and a dramatic shift in the way technologies can be used to
streamline workflow while facilitating effective trial management. Providing
interoperability among systems, including the IMPACT(®) Clinical Trial
Management System (CTMS), the DataLabs(®) EDC solution, and the ClinPhone(®)
Randomization and Trial Supply Management (RTSM) technologies, the eClinical
Suite supports real-time data interchange and enables diverse applications to
work synergistically. For more information about Perceptive's eClinical Suite,
visit http://www.perceptive.com/Solutions/eClinical-Suite.html.

Note: Perceptive's Randomization and Trial Supply Management (RTSM) solutions
incorporate functionality that is often referenced as Interactive Voice and
Web Response Systems (IVRS/IWRS).

About Perceptive Informatics
Perceptive Informatics, a leading eClinical solutions provider and subsidiary
of PAREXEL, is focused on helping customers to accelerate the product
development process through innovation. The Perceptive Informatics
industry-leading eClinical product portfolio is built on advanced technology
that benefits from extensive medical and clinical expertise as well as a deep
understanding of the regulatory environment. The portfolio includes
Randomization and Trial Supply Management (RTSM) technologies, Medical
Imaging, Clinical Trial Management Systems (CTMS), Electronic Data Capture
(EDC), and Electronic Patient-Reported Outcomes (ePRO). For more information
about the integrated solutions in Perceptive's eClinical Suite visit:
www.perceptive.com.

About PAREXEL International
PAREXEL International Corporation is a leading global biopharmaceutical
services organization, providing a broad range of knowledge-based contract
research, medical communications and consulting services to the worldwide
pharmaceutical, biotechnology and medical device industries. Committed to
providing solutions that expedite time-to-market and peak-market penetration,
PAREXEL has developed significant expertise across the development and
commercialization continuum, from drug development and regulatory consulting
to clinical pharmacology, clinical trials management, medical education and
reimbursement. Perceptive Informatics, Inc., a subsidiary of PAREXEL, provides
advanced technology solutions, including medical imaging, to facilitate the
clinical development process. Headquartered near Boston, Massachusetts,
PAREXEL operates in 70 locations throughout 52 countries around the world, and
has over 9,130 employees. For more information about PAREXEL International
visit www.PAREXEL.com.

This release contains "forward-looking" statements regarding future results
and events. For this purpose, any statements contained herein that are not
statements of historical fact may be deemed forward-looking statements.
Without limiting the foregoing, the words "believes," "anticipates," "plans,"
"expects," "intends," "appears," "estimates," "projects," "targets," and
similar expressions are also intended to identify forward-looking statements.
The forward-looking statements in this release involve a number of risks and
uncertainties. The Company's actual future results may differ significantly
from the results discussed in the forward-looking statements contained in this
release. Important factors that might cause such a difference include, but are
not limited to, risks associated with: actual operating performance; actual
expense savings and other operating improvements resulting from recent
restructurings; the loss, modification, or delay of contracts which would,
among other things, adversely impact the Company's recognition of revenue
included in backlog; the Company's dependence on certain industries and
clients; the Company's ability to win new business, manage growth and costs,
and attract and retain employees; the Company's ability to complete additional
acquisitions and to integrate newly acquired businesses or enter into new
lines of business, including, but not limited to, the successful business
integration and anticipated synergy achievements in connection with the
ClinPhone acquisition; the impact on the Company's business of government
regulation of the drug, medical device and biotechnology industry;
consolidation within the pharmaceutical industry and competition within the
biopharmaceutical services industry; the potential for significant liability
to clients and third parties; the potential adverse impact of health care
reform; and the effects of exchange rate fluctuations and other international
economic, political, and other risks. Such factors and others are discussed
more fully in the section entitled "Risk Factors" of the Company's Annual
Report on Form 10-K for the year ended June 30, 2009 as filed with the SEC on
August 28, 2009, which "Risk Factors" discussion is incorporated by reference
in this press release. The forward-looking statements included in this press
release represent the Company's estimates as of the date of this release. The
Company specifically disclaims any obligation to update these forward-looking
statements in the future. These forward-looking statements should not be
relied upon as representing the Company's estimates or views as of any date
subsequent to the date of this press release.

PAREXEL is a registered trademark of PAREXEL International Corporation, and
Perceptive Informatics is a trademark of Perceptive Informatics, Inc. All
other names or marks may be registered trademarks or trademarks of PAREXEL
International Corporation, Perceptive Informatics, Inc. or their respective
owners and are hereby acknowledged.

Contacts:
Jennifer Baird, Senior Director of Gene Carozza/Kim Baker
Public Relations
PAREXEL International PAN Communications
Tel: +781-434-4409 Tel: +978-474-1900
Email: Jennifer.Baird@PAREXEL.com Email: PAREXEL@pancomm.com

SOURCE PAREXEL International Corporation

Jennifer Baird, Senior Director of Public Relations of PAREXEL International,
+1-781-434-4409, Jennifer.Baird@PAREXEL.com; or Gene Carozza or Kim Baker,
both of PAN Communications for PAREXEL International, +1-978-474-1900,
PAREXEL@pancomm.com